Landmark Bill Modernizes Colorado THC Drinks Sales | Vicente LLP
The colorado thc drinks sales legislation aims to modernize cannabis beverage regulations in Colorado. This policy change affects patient dosing consistency and product quality control. Clinicians should monitor these updates for improved therapeutic…
Canna-basics: What to Expect at a Dispensary and More for New Cannabis Users
Patient education cannabis dispensary basics are essential for new users to navigate product choices and dosing safely. Understanding dispensary guidance reduces risks of inappropriate product use. Clinicians should support patients with clear cannabis…
Planet 13 Launches Dreamland Cannabis Chocolate in Florida
Commercial cannabis edible launches such as Planet 13's Dreamland chocolate influence patient dosing precision and clinical outcomes. Understanding these products' formulation and pharmacokinetics helps clinicians guide patients safely. This update…
Washington Post: What the research says about what cannabis is really doing to your brain.
Cannabis brain effects research reveals acute cognitive impacts such as memory and attention deficits during intoxication. Long-term heavy use may influence executive function, though causality is debated. Recovery of cognitive functions often occurs…
New to THC? Why Low-Dose Cannabis Formulations Matter for Beginners
Low-dose cannabis formulations address a critical clinical need for cannabis-naive patients. These products enable safer THC initiation by reducing adverse effects from standard dosing. Standardized low-dose cannabis formulations allow precise titration…
Cannabinoid Use Linked to Bidirectional Inflammatory Responses: A Review
The bidirectional inflammatory response cannabinoids produce is key to understanding cannabis effects on inflammation. This response explains why cannabis can have both pro- and anti-inflammatory effects. Clinical variability highlights the need for…
Missouri Advances Licensed Cannabis Research Programs
Missouri is advancing licensed cannabis research programs to build a stronger clinical evidence base. These programs enable state-level studies on dosing, safety, and therapeutic applications. Licensed cannabis research programs are critical for…
High-Potency Cannabis: America’s New Pastime and Psychiatry’s Next Challenge
High-potency THC products dominate the US cannabis market, posing new challenges for psychiatry. These products require updated dosing guidelines and harm reduction strategies. Understanding high-potency THC products is essential for clinical assessment…
Examining CBD Bioavailability Challenges and Precision Claims
CBD bioavailability challenges remain a significant barrier to precision delivery in cannabis therapeutics. Claims of precision CBD delivery require rigorous clinical evidence to ensure dosing consistency. Without peer-reviewed pharmacokinetic data,…
Feds Launch Campaign Warning Against Marijuana-Impaired Driving Ahead Of 4/20
Federal agencies have launched a campaign warning about marijuana impaired driving ahead of 4/20. This campaign highlights the importance of understanding cannabis impairment. Clinicians should guide patients on safe cannabis use and driving risks.
